News
-
-
-
-
PRESS RELEASE
GPO Plus, Inc. To Participate in a Live Investor Discussion on Its Progress Hosted By Buffalo Fireside Chats
Join CEO Brett H. Pojunis on X Spaces for a live investor discussion about revenue growth and upcoming opportunities with GPO Plus, Inc. (OTCQB:GPOX). Fireside Chat on 11/26/2025 at 12:00 PM EST -
-
-
-
-
-
PRESS RELEASE
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells
Telomir Pharmaceuticals reports preclinical findings showing Telomir-1 reduces PSA levels in prostate cancer cells, indicating potential treatment response. CEO and scientific perspectives highlighted